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RNA was isolated from induced P3HRl cells which synthesize Epstein-Barr virus 
(EBV) particles and therefore a full set of early and late antigens and from induced 
Raji cells which synthesize only early EBV proteins and hybridized to cloned EBV- 
DNA fragments spanning the entire genome. Bound mRNA was eluted and translated 
in vitro with rabbit reticulocyte lysate. The translation products were analyzed on SDS- 
polyacrylamide gels either directly or after immunoprecipitation with human sera. Most 
proteins could be mapped to short defined regions of the EBV genome using short 
restriction fragments and overlapping sheared fragments and there is evidence of 
splicing for some mRNA species. The synthesis of five early proteins can be seen only 
with hybrid-selected RNA from induced Raji cells. These mRNAs seem to be enriched 
in the cells restricted to early antigen synthesis. 0 1985 Academic press, IN. 
INTRODUCTION 
No efficient lytic system is available for 
the production of Epstein-Barr virus 
(EBV), thus the major sources of viral 
RNA, viral proteins, and virus particles 
are lymphoblastoid cell lines. A though 
all cell lines used contain viral A nomes 
in every single cell, some lines cannot 
produce virus. For example Raji, hich is 
originally derived from a Burkit ‘s lym- 
phoma, synthesizes only the EBV 
I 
uclear 
antigen (EBNA). Others, e.g., B 5-8 (in 
witro transformed marmoset lymp ocytes) 
or P3HRl (also derived from a B rkitt’s 
lymphoma) spontaneously produc early 
antigen (EA), virus capsid antigen (VCA), 
and membrane antigen (MA), but bnly in 
a small almost constant fraction of cells. 
After induction with chemicals, uch as 
butyric acid (Luka et a& 1981) or horbol 
esters (TPA) (zur Hausen et d, 19 8), the 
percentage of cells synthesizing E 
tion (Lenoir, 1979). 
1 
V an- 
tigens increases in producer ccl lines. 
Raji cells only synthesize EA after, induc- 
Virus produced by P3HRl cells, but not 
that derived from B95-8 cells, can be used 
’ Author to whom requests for reprints should be 
addressed. 
to superinfect Raji cells which then enter 
into a lytic cycle of virus replication. On 
the other hand, P3HRl virus has lost its 
ability to transform lymphocytes. This 
may correlate with a deletion in the left 
part of the EBV genome, since the trans- 
forming capacity can be rescued after 
replacement of the lost DNA by recom- 
bination (Skare et al, 1981; Stoerker et 
a& 1983). The consequences on molecular 
level of a 13-kb deletion in the right part 
of the B95-8 DNA are still obscure. 
Transcribed regions on the EBV genome 
in noninduced and iododeoxyuridine-in- 
duced Raji cells (King et a& 1981) and 
EBV proteins in Raji cells induced by 
butyric acid and TPA (Mueller-Lantzsch 
et a& 1979; Kawanishi et al, 1981b; Bayliss 
et al, 1983; Kallin and Klein, 1983) have 
been identified. EBV proteins in the pro- 
ductive cycle have been studied in induced 
P3HRl cells (Mueller-Lantzsch et uL, 1979; 
Kallin et al, 1979; Kawanishi et aL, 1981a; 
Edson and Thorley-Lawson, 1981) and ex- 
tensively in superinfected Raji cells (Bay- 
liss and Wolf, 1981, 1982). In B95-8 cells 
(Hummel and Kieff, 1982a) and in a cel- 
lular subclone of P3HRl cells (Weigel and 
Miller, 1983), EBV mRNAs have been 
mapped to specific restriction fragments 
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of the EBV DNA. By hybrid-selected 
translation with RNA from B95-8 cells, 
the coding regions for many EBV proteins 
have been mapped on the genome (Hum- 
me1 and Kieff, 1982b). 
We have mapped EBV proteins of in- 
duced P3HRl cells and early EBV proteins 
of induced Raji cells by translating hybrid- 
selected mRNA using cloned EBV-DNA 
fragments spanning the entire genome. 
Many proteins could be mapped more 
precisely and differences between the EBV 
strains could be documented. A repeat 
region in the EBV BumHl K fragment 
which is transcribed from EBV DNA 
(Heller et d, 1982a) encodes part of EBNA 
(Hennessy and Kieff, 1983) and hybridizes 
to cellular DNA (Heller et uZ., 198213). This 
fragment selected a translatable mRNA 
from EBV-negative cells which would in- 
dicate that the homologous region within 
the cellular DNA is also transcribed. 
MATERIALS AND METHODS 
Tissue culture and RNA preparation. 
P3HR1, Raji, and BJAB cells were grown 
in RPM1 1640 culture medium supple- 
mented with 10% heat-inactivated fetal 
calf serum. P3HRl and Raji cells were 
induced with 40 rig/ml TPA and 3 mM 
butyric acid. For in viva labeling of pro- 
teins, the cells were labeled 3 days after 
induction in methionine-free MEM with 
50 PCi [?S]methionine (NEN) per milliliter 
for 4 hr. After washing, the cells were 
lysed in immunoprecipitation buffer. 
RNA was prepared by lysing the cells 
2 days after induction with 4 M guanidine 
isothiocyanate (Fluka), 0.5 M 2-mercap- 
toethanol, and 50 mM sodium acetate, pH 
5.5 (Chirgwin et al, 1979). The lysate was 
centrifuged for 1 hr at 20,000 rpm in a 
SW-41 rotor (50,000 g) and the superna- 
tant layered on top of 2 ml CsCl (density 
1.8 g/cm3) in 10 mM triethanolamine and 
1 mM EDTA, pH 7.4. After centrifugation 
for 17 hr at 150,000 g and 15” the RNA 
pellet was dissolved in water, extracted 
with chloroformN% isoamyl alcohol, and 
precipitated with ethanol. 
EBVDNA. The following cloned EBV- 
DNA fragments were isolated using stan- 
dard procedures: Overlapping, sheared 
fragments from the B95-8 strain of EBV 
cloned in Charon 4A (Buell et d, 1981). 
BamHl restriction fragments from the 
B95-8 strain cloned in pBR 322 (Skare and 
Strominger, 1980). Subclones from Charon 
4A EB 90-99 (M 3-1-1, M 3-5-6) cloned in 
pUC8 (Motz and Wolf, unpublished re- 
sults). Restriction fragments from EBV- 
strain M-ABA containing the region which 
is deleted in B95-8 (H3-Dl, H3-K2, H3- 
D2) and the terminal fragment (966-20) 
from circularized M-ABA DNA (Polack et 
al., 1984). 
H&rid selection DNA (8 pg) was soni- 
cated 3 X 60 set to give DNA fragments 
of approximately 1000 bp, incubated for 
10 min at 100” and spotted on a nitrocel- 
lulose filter (about 5 X 5 mm, Schleicher 
& Schiill BA85). The filter was dried, 
washed in 6X SSC (0.9 M NaCl, 0.09 M 
Na3-citrate), and baked for 2 hr at 80”. 
Two filters were hybridized in 100 ~1 65% 
formamide (BRL), 0.4 M NaCl, 10 mM 
PIPES (Sigma), pH 7.0, containing 100 pg 
total cellular RNA for 2.5 hr at 52”. The 
filters were washed extensively with 1X 
SSC, 0.5% SDS (62”), and 2 mM EDTA. 
Bound mRNA was eluted by boiling the 
filters for 75 set in 300 gl double-distilled 
water, and was ethanol precipitated to- 
gether with 20 pg calf liver tRNA (Boeh- 
ringer-Mannheim). 
In vitro translation, immunoprecipita- 
tion, and SDS-PAGE. The RNA was in 
vitro translated with a mRNA-dependent 
rabbit reticulocyte lysate prepared ac- 
cording to Pelham and Jackson (1976). 
r5S]Methionine (NEN) was used as radio- 
active amino acid. The probes were either 
loaded directly onto 10 or 12.5% SDS- 
polyacrylamide gels (Bayliss and Wolf, 
1981) after heating with electrophoresis 
sample buffer (50 mM Tris, pH 7.0, 2% 
SDS, 5% 2-mercaptoethanol, 30% sucrose) 
or mixed with immunoprecipitation buffer 
(1% Triton X-100,0.1% SDS, 0.137 M NaCl, 
1 mM CaCl,, 1 mM MgClz, 10% glycerol, 
20 mM Tris, pH 9.0; 0.01% NaN3 and 1 
mM PMSF), and used for immunoprecip- 
itation (Bayliss et aL, 1983). Five micro- 
liters of a pool of human sera from pa- 
tients with nasopharyngeal carcinoma 
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(EBNA 1:400, EA 1:1200, VCA 1:6600) was 
used for one assay after preincubation 
with a protein extract from 5 X lo6 un- 
labeled EBV-negative BJA-B cells. The 
immune complexes were bound on protein 
A-Sepharose (Pharmacia), washed, eluted 
by boiling the beads in electrophoresis 
sample buffer, and loaded onto the SDS- 
polyacrylamide gels. These were stained, 
fixed, dried, and exposed to 3H ultrofilm 
(LKB). 
RESULTS 
Mapping of Proteins in Induced P.?HRl 
Cells 
Total cellular RNA from induced P3HRl 
cells was isolated and translated in vitro 
with rabbit reticulocyte lysate. The trans- 
lation products were immunoprecipitated 
and EBV-specific proteins were identified 
on SDS-polyacrylamide gels. Immunopre- 
cipitated translation products with RNA 
from EBV-negative BJA-B cells were used 
as control. A large number of in vitro 
translated EBV proteins ranging from 
150 to 18 kDa were identified. 
After a first comparison with immuno- 
precipitations of in vivo labeled induced 
P3HRl cells most proteins seemed to 
comigrate with a protein of the same 
molecular weight (Fig. 1). However, using 
a panel of different sera for comparative 
immunoprecipitation we could not confirm 
the identity of the in tivo labeled and the 
in vitro translated proteins of the same 
molecular weight with the exception of 
the proteins 150, 143, 138, and 90 kDa. 
The latter proteins were recognized or 
not recognized by all sera we have tested 
in a coordinated way from the in vitro 
translation products and the in viva la- 
beled cell lysates. All other proteins failed 
to react with all sera in this strict sense. 
Either monospecific sera or monoclonal 
antibodies are necessary to prove immu- 
nologically the relationship of the in vitro 
translated proteins and their in wivo la- 
beled counterparts. 
After hybridization of the P3HRl RNA 
to cloned EBV-DNA fragments and in 
vitro translation of the bound mRNA all 
identified EBV proteins could be mapped 
to discrete regions of the genome (Fig. 2). 
23bm 
r*c- 
FIG. 1. Comparison of in viva labeled and in vitro 
translated EBV proteins. A: In vitro translation of 
RNA from P3HRl cells. B: Extract of in viva labeled 
P3HRl cells. The proteins were immunoprecipitated 
and resolved on a SDS-polyacrylamide gel. The 
apparent molecular weights are given in daltons X 
10-3. 
As compared to translation from unsep- 
arated RNA more EBV proteins could be 
identified because some mRNA species 
were enriched by the hybridization pro- 
cedure and a few translated proteins were 
only visible after separation from the 
most prominent bands. Moreover different 
proteins of the same molecular weight 
seem to exist which are resolved only 
after mapping to different parts of the 
genome. Using the BamHl fragments, two 
fragments which subdivide the BamHl A 
fragment and the overlapping sheared 
fragments, the coding regions of most 
proteins could be mapped to narrow re- 
gions of the genome. 
Using fragments from the M-ABA 
strain spanning the deletion in the B95-8 
strain and a plasmid containing the EGO 
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D and Eco I fragment from circular M- 
ABA DNA no additional protein could be 
detected by translation of hybrid-selected 
mRNA. 
Some proteins map within a single 
BamHl restriction fragment or even in a 
segment of one fragment, e.g., the 47-kDa 
protein in the BamHl M fragment, and 
the 33- and the 19-kDa proteins in the 
BamHl L fragment. The 23-kDa protein 
is also mainly coded by the BamHl L 
fragment, but the mRNA hybridizes with 
marginal significance also to the neigh- 
boring BamHl M and S fragments. The 
44- and 29-kDa proteins map in the 
BamHl K, the 31- and the 150-kDa pro- 
teins in the BamHl D fragment. The 34- 
kDa protein maps in the BamHl B frag- 
ment and the 96-, 43-, 41.5-, and 40.5-kDa 
proteins map in the left part of the 
BamHl A fragment. 
Some proteins map in two neighboring 
fragments, therefore the reading frame 
probably extends across the restriction 
site. The l&kDa protein maps in the 
BamHl H and the left part of the BumHl 
F fragment, the SO-kDa protein in the 
BamHl 0 and a fragments, the 36-kDa 
protein in the BamHl a and M fragments, 
the 3’7.5-, 34-, 31-, and 30-kDa proteins in 
the BamHl M and S fragments, the 92- 
and 75-kDa proteins in the BamHl Z and 
R fragments, the 80-kDa protein in the 
BamHl R and K fragments, the 45-kDa 
protein in the BumHl B and G fragments, 
the 35-kDa protein in the BamHl G and 
the left part of the BamHl D fragment, 
the 73- and the 69-kDa proteins in the 
BumHl T and X fragments, the 49-, 41-, 
26.5-, 25-, and 21-kDa proteins in the 
BamHl d and I fragments. 
The 13%kDa protein and the 143-kDa 
protein map in the right part of BamHl 
A and the BamHl C fragment, respec- 
tively. Their reading frames can, however, 
expand to the terminal BamHl fragments 
which we have not tested. It is not possible 
to answer this question using the EcoRl 
D and I fragment from circular EBV 
DNA which contains the terminal BumHl 
fragments of the linear DNA because the 
fragments overlap. 
In some cases proteins of the same 
molecular weight map in different parts 
of the genome. The BamHl F fragment, 
the neighboring fragments BamHl 0 and 
a and the BamHl Z and D fragments code 
for a protein of 40 kDa. The existence of 
different independent EBV-specific pro- 
teins of the same molecular weight is the 
most reasonable explanation. It is also 
possible that this protein is spliced and 
the exons map in the different fragments. 
Splicing is more evident in the BumHl 
V, d, and I region. Proteins of 140, 64, 46, 
and 35 kDa code in the BamHl V and I 
fragments, but not in the small BumHl d 
fragment which is between them. The 
simultaneous occurrence of four proteins 
in the two separated BamHl fragments 
suggests a splicing event. The four pro- 
teins may be either the result of incorrect 
termination or initiation of the translation 
or due to the presence of partly and 
completely spliced mRNAs or due to het- 
erogeneous splicing of the primary tran- 
scription product. As observed with herpes 
simplex virus type 1 (Frink et a& 1983), 
introns of different lengths may be spliced 
out. The inability of these mRNA species 
to hybridize to the BamHl d fragment is 
not due to technical problems since the 
mRNAs for other proteins which map in 
the neighboring BamHl I and d fragments 
hybridized in reasonable quantities. 
It is also possible that the mRNA for 
the llO-kDa protein is spliced. The protein 
maps in the BamHl d and I fragments 
and in the right part of the BamHl A 
fragment but not in the left part. The 
FIG. 2. Hybrid-selected translation with RNA from P3HRl cells. RNA from induced P3HRl 
cells was hybridized to the cloned EBV-BamHl fragments indicated by the letters and to two 
clones which subdivide the BumHl A fragment (M 3-l-l and M 3-5-6, see Fig. 6 for map). The 
selected mRNA was translated in vitro with rabbit reticulocyte lysate. The translated proteins 
were immunopreeipitated and analyzed on SDS-polyacrylamide gels. The EBV proteins are 
indicated in each fragment with their molecular weights in daltons X lo-‘. 
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llO-kDa protein from the BumHl L frag- 
ment is probably independent. 
The mRNA for the 4%kDa protein also 
seems to be spliced. BamHl restriction 
fragments 0, a, Z, R, K, B, and G code 
for a protein of this size. If the 4%kDa 
protein encoded by BumHl Z, R, K, B, 
and G is a single protein the mRNA has 
to be spliced, the 4%kDa protein mapping 
in the BamHl 0 and a fragments may be 
unrelated to this protein. 
Mapping of Proteins in Induced Raji Cells 
All proteins mapped with RNA from 
induced Raji cells are assumed to be early 
proteins. RNA from induced Raji cells 
was hybridized to cloned EBV-DNA frag- 
ments. The bound mRNA was eluted and 
translated in vitro with rabbit reticulocyte 
lysate. The translation products were an- 
alyzed in SDS-polyacrylamide gels with- 
out immunoprecipitation to identify even 
early proteins against which antibodies 
are not present in the human sera used. 
Thirteen proteins could be identified (Fig. 
3). The 1%kDa polypeptide in the BumHl 
fragments H and F and the 40- and 39.5- 
kDa proteins in the BamHl F fragment 
are probably identical to the correspond- 
ing proteins in induced P3HRl cells. Sim- 
ilarly, the 47-kDa protein in Charon 4A 
EB 38-47 and EB 45-54, the 90-kDa protein 
in EB 38-4’7, the 48-kDa protein in EB 61- 
72 and EB 69-79, and the 73- and 69-kDa 
proteins in EB 75-84 and EB 83-93 seem 
to be identical to corresponding, more 
precisely mapped proteins in induced 
P3HRl cells. 
The 47-, 41-, and 35-kDa proteins in the 
BumHl F fragment, the 96-kDa protein 
in Charon 4A EB 53-61, and the 105-kDa 
protein in Charon 4A EB 83-93 could not 
be identified among the proteins in in- 
duced P3HRl cells because the early 
mRNAs for these proteins are enriched 
in induced Raji cells. The 105-kDa protein 
is the only one of them which could not 
be immunoprecipitated. None of these five 
proteins is visible after hybrid selected 
translation with RNA from P3HRl cells 
and direct resolution of the translation 
products on SDS-polyacrylamide gels 
without immunoprecipitation. 
Identification of a Translatable mRNA in 
EBV-Negative BJA Cells, Which Hy- 
bridizes to EBV DNA 
RNA from EBV-negative BJA-B cells 
was hybridized to cloned EBV-DNA frag- 
ments, and the bound mRNA was eluted 
and translated in vitro. The translation 
products were analyzed on SDS-poly- 
acrylamide gels. The EBV BumHl K frag- 
ment, a part of the Charon 4A EB 61-72, 
selects cellular mRNA which can be 
translated in vitro into two proteins of 92 
and 84 kDa (Fig. 4). This fragment is the 
only one which selects a translatable cel- 
lular mRNA (Fig. 5). These two proteins 
were also translated with mRNA from 
P3HRl and Raji cells transcribed from 
the EBV-BumHl K fragment or the ho- 
mologous cellular sequences. Translation 
of hybrid-selected RNA from highly in- 
duced P3HRl or Raji cells, however, failed 
to detect the respective proteins. 
DISCUSSION 
A map summarizes the identified EBV 
proteins in induced Raji and induced 
P3HRl cells (Fig. 6). Coding regions are 
drawn with maximum exclusion of non- 
hybridizing DNA. With the exception of 
slight differences in the molecular weight 
most proteins have also been mapped with 
RNA from B95-8 cells (Hummel and Kieff, 
1982b). We have mapped most polypep- 
tides more precisely using smaller restric- 
tion fragments and overlapping sheared 
fragments covering the entire EBV ge- 
nome. Some additional proteins could be 
identified, others were not detected in our 
experiments. This could be due to different 
expression of the EBV genome in the cell 
lines. P3HRl and Raji cells are human 
lymphoblastoid cell lines, whereas B95-8 
is an in vitro transformed marmoset cell 
line. The pattern of EBV proteins in 
P3HRl and B95-8 cells shows some differ- 
ences (Bayliss and Wolf, unpublished ob- 
servations). This is well documented for 
the major glycoproteins. B95-8 cells pro- 
duce mostly gp350 whereas P3HRl cells 
produce mostly gp220. The unglycosylated 
precursor for the gp350 is 135 kDa, that 
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FIG. 3. Hybrid-selected translation with RNA from chemically induced Raji cells. RNA from 
induced Raji cells was hybridized to cloned EBV-BumHl fragments and to sheared DNA 
fragments cloned in Charon-4A as indicated (for map, see Fig. 6). The selected mRNA was 
translated in vitro with rabbit reticuloeyte lysate and the translation products were analyzed on 
an SDS-polyacrylamide gel. The identified proteins were indicated in each fragment with their 
molecular weights in daltons X 10-z. 
for the gp220 is less than 120 kDa, but 
they share amino acid sequences (Edson 
and Thorley-Lawson, 1983). By hybrid- 
selected translation with RNA from B95- 
8 cells, a 135-kDa protein, the precursor 
of gp350, and a lOO-kDa protein, the pre- 
cursor of gp220, was mapped in the 
BamHl L fragment (Hummel et al, 1984). 
With RNA from P3HRl cells, we could 
map a llO-kDa protein-the potential 
precursor of gp220-to the BumHl L 
fragment. 
We could not select translatable RNA 
with the BumHl W, Y, Q, U, and P 
fragments. The BumHl Y fragment is 
deleted in P3HRl DNA, so no protein is 
expected. No transcript could be mapped 
to the BumHl Q, U, and P fragment 
(Hummel and Kieff, 1982a; Weigel and 
Miller, 1983) and to the BumHl W frag- 
ment no polypeptide could be mapped in 
producing B95-8 cells (Hummel and Kieff, 
198213). However, we could map proteins 
in the BamHl S fragment, which seems 
to be silent in B95-8 cells. 
It was not possible to identify gene 
products of EBV expressed during latency 
with hybrid-selected translation. No EBV- 
specific protein could be mapped to the 
EBV genome using RNA from uninduced 
Raji cells and none of the mapped proteins 
from P3HRl cells and induced Raji cells 
could be correlated to EBV-specific pro- 
teins expressed during latency. 
In some restriction fragments the cod- 
ing capacity is too small to code for all 
the proteins we mapped. There are several 
possible explanations. 
(i) Some proteins may be artificial 
products of the in vitro translation due to 
incorrect termination or internal initia- 
tion. This may have happened preferen- 
tially with the mRNA of the BumHl D 
fragment coding for the 150-kDa protein. 
At least some of the protein ladder 140- 
102 kDa are shorter fragments of the 150- 
kDa protein because they were not visible 
in other experiments. 
(ii) Unspliced and partly spliced mRNA 
species may be present in the RNA prep- 
aration and may produce longer or shorter 
(if a present intron contains a stop codon) 
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FIG. 4. Hybrid-selected translation with RNA from P3HRl and BJA-B cells. RNA from EBV- 
negative BJA-B cells and from induced P3HRl-cells was hybridized to the EBV-BumHI fragments 
R, K, and B, and the selected mRNAs were analyzed as described in Fig. 3. From induced P3HRl 
cells, the same population of mRNAs as in Fig. 2 hybridized to the cloned BamHl fragments. 
Due to the higher background without immunoprecipitation, not all proteins are visible. The 
BomHl K fragment, but not the neighboring fragments, selects mRNAs which can be translated 
in vitro into proteins of 92 and 34 kDa. These proteins are not visible after hybrid-selected 
translation with RNA from induced P3HRl cells due to the effects of the inducing agents. 
proteins than the completely spliced 
mRNA. For example, the 140-, 64-, 46-, 
and 35-kDa proteins are probably related 
to each other and represent parts of the 
140-kDa protein. 
(iii) If the mRNA is spliced, only a 
short stretch in the DNA fragment in 
question has to be represented in the 
transcript to bind the mRNA, which is 
translated into the entire protein. 
(iv) Overlapping mRNA species which 
are translated into different proteins and 
mRNA species which include the coding 
regions for different independent polypep- 
tides may result in a particular protein 
pattern in some fragments. These phe- 
nomena have been described for herpes 
simplex virus type 1 (Anderson et al, 
1981; Draper et aZ., 1982; McLauchlan and 
Clements, 1983; Frink et cd, 1983; Costa 
et aL, 1983). Some proteins with slightly 
differing molecular weights coding in the 
same fragment (e.g., 40- and 39.5-kDa 
proteins in the BamHl F, 40- and 39-kDa 
proteins in the BamHl Z, and ‘73- and 69- 
kDa proteins in the BumHl T and X 
fragments) may be a result of initiation 
of translation at different sites. This is 
also documented for herpes simplex virus 
type 1 (Marsden et al, 1983). 
Recent Sl-mapping data (T. Gibson, P. 
Stockwell, M. Ginsberg, and B. Barell, per- 
sonal communication) suggest that mRNA 
species containing the information for two 
proteins are also transcribed from EBV 
DNA. Early in infection, an open reading 
frame of 2.7 kb is transcribed rightward 
from a promotor in the BczmHl 0 frag- 
ment to a polyadenylation signal in the 
BumHl a fragment. The same reading 
frame is also transcribed from a second 
10 
FIG. 5. Hybrid-selected translation with RNA from BJA-B cells. RNA from EBV-negative BJA- 
B cells was hybridized to sheared EBV-DNA fragments cloned in Charon 4A and to a segment of 
the large internal repeat cloned as BamHl fragment in pBR 322. The selected mRNA was 
analyzed as described in Fig. 3. Only the Charon 4A EB 61-72, which contains the BurnHl K 
fragment selects mRNA, which can be translated into proteins of 92 and 34 kDa. 
promotor at least 1.0 kb further upstream 
from the first one. The additional sequence 
contains a second open reading frame of 
about 1.2 kb. The 2.7-kb reading frame is 
presumably translated into a 90-kDa 
polypeptide, as we mapped a protein of 
90 kDa to the BamHl 0 and a fragments. 
The 1.2-kb reading frame is with marginal 
significance translated into a polypeptide 
of 40 or 48 kDa. Though the 1.2-kb reading 
frame is contained completely within the 
BamHl 0 fragment, the described mRNA 
would hybridize both to the BamHl 0 
and BamHl a fragments. Therefore, after 
hybrid-selected translation, a protein of 
40 or 48 kDa would map in the BamHl 0 
and a fragments as detected in our exper- 
iments. The observation that cytoplasmic 
polyadenylated mRNAs of 4.5 and 3.1 kb 
>mapped in the BamHl 0 and a fragments 
(Hummel and Kieff, 1982a) support our 
suggestion. 
By hybridization of RNA from EBV- 
negative RJA-B cells to the cloned BamHl 
K fragment we could select a cellular 
mRNA which is translatable in vitro to 
proteins of 84 and 92 kDa. This fragment 
contains an unusual repeat which is tran- 
scribed in latent and productive infection 
(Heller et al, 1982a) and hybridizes to 
cellular DNA (Heller et aC, 1982b). Our 
results indicate that the cellular equiva- 
lent of the repeat region is also tran- 
scribed in FLEA-B cells. 
Due to the high GC content (74%) of 
the repeat region, hybridization results 
should be interpreted carefully. Further 
experiments are necessary to strengthen 
the supposition that transcription of the 
homologous region in the cellular genome 
occurs. 
Maitland et al. (1981) reported that cer- 
tain restriction fragments of HSV 2 hy- 
bridized to human placental RNA under 
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FIG. 6. Map of the polypeptides translated after hybrid selection. The coding regions of the 
proteins are drawn as maxima1 exclusion of noncoding sequences relative to the BumHl restriction 
fragments of EBV DNA and the DNA clones used for hybridization. The deletion in B95-8 cells 
combining the BamHl fragments B’. W’, and I’ to the BamHl fragment I is indicated as a dotted 
line. The proteins are indicated with their molecular weights in daltons X 10m3. 
high stringency. The map locations of 
these fragments coincide with the inverted 
repeats where Peden et aL (1982) reported 
homology with repetitive mammalian se- 
quences. Immediate early mRNAs code in 
this region (Clements et aL, 1977; Easton 
and Clements, 1980). If EBNA is regarded 
as an immediate early protein, the agree- 
ment between HSV and EBV is remark- 
able. 
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